PatientsVille.com Logo

LIVER FUNCTION TEST ABNORMAL and Genteal

PatientsVille

LIVER FUNCTION TEST ABNORMAL Symptoms and Causes

What is fatty liver disease?

Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Fatty liver disease is a condition in which fat builds up in your liver. There are two main types:

  • Nonalcoholic fatty liver disease (NAFLD)
  • Alcoholic fatty liver disease, also called alcoholic steatohepatitis
What is nonalcoholic fatty liver disease (NAFLD)?

NAFLD is a type of fatty liver disease that is not related to heavy alcohol use. There are two kinds:

  • Simple fatty liver, in which you have fat in your liver but little or no inflammation or liver cell damage. Simple fatty liver typically does not get bad enough to cause liver damage or complications.
  • Nonalcoholic steatohepatitis (NASH), in which you have inflammation and liver cell damage, as well as fat in your liver. Inflammation and liver cell damage can cause fibrosis, or scarring, of the liver. NASH may lead to cirrhosis or liver cancer.
What is alcoholic fatty liver disease?

Alcoholic fatty liver disease is due to heavy alcohol use. Your liver breaks down most of the alcohol you drink, so it can be removed from your body. But the process of breaking it down can generate harmful substances. These substances can damage liver cells, promote inflammation, and weaken your body's natural defenses. The more alcohol that you drink, the more you damage your liver. Alcoholic fatty liver disease is the earliest stage of alcohol-related liver disease. The next stages are alcoholic hepatitis and cirrhosis.

Who gets fatty liver disease?

Researchers do not know the cause of nonalcoholic fatty liver (NAFLD). They do know that it is more common in people who

  • Have type 2 diabetes and prediabetes
  • Have obesity
  • Are middle aged or older (although children can also get it)
  • Are Hispanic, followed by non-Hispanic whites. It is less common in African Americans.
  • Have high levels of fats in the blood, such as cholesterol and triglycerides
  • Have high blood pressure
  • Take certain drugs, such as corticosteroids and some cancer drugs
  • Have certain metabolic disorders, including metabolic syndrome
  • Have rapid weight loss
  • Have certain infections, such as hepatitis C
  • Have been exposed to some toxins

NAFLD affects about 25 percent of people in the world. As the rates of obesity, type 2 diabetes, and high cholesterol are rising in the United States, so is the rate of NAFLD. NAFLD is the most common chronic liver disorder in the United States.

Alcoholic fatty liver disease only happens in people who are heavy drinkers, especially those who have been drinking for a long period of time. The risk is higher for heavy drinkers who are women, have obesity, or have certain genetic mutations.

What are the symptoms of fatty liver disease?

Both NAFLD and alcoholic fatty liver disease are usually silent diseases with few or no symptoms. If you do have symptoms, you may feel tired or have discomfort in the upper right side of your abdomen.

How do I know if I have fatty liver disease?

Because there are often no symptoms, it is not easy to find fatty liver disease. Your doctor may suspect that you have it if you get abnormal results on liver tests that you had for other reasons. To make a diagnosis, your doctor will use

  • Your medical history
  • A physical exam
  • Various tests, including blood and imaging tests, and sometimes a biopsy

As part of the medical history, your doctor will ask about your alcohol use, to find out whether fat in your liver is a sign of alcoholic fatty liver disease or nonalcoholic fatty liver (NAFLD). He or she will also ask which medicines you take, to try to determine whether a medicine is causing your NAFLD.

During the physical exam, your doctor will examine your body and check your weight and height. Your doctor will look for signs of fatty liver disease, such as

  • An enlarged liver
  • Signs of cirrhosis, such as jaundice, a condition that causes your skin and whites of your eyes to turn yellow

You will likely have blood tests, including liver function tests and blood count tests. In some cases you may also have imaging tests, like those that check for fat in the liver and the stiffness of your liver. Liver stiffness can mean fibrosis, which is scarring of the liver. In some cases you may also need a liver biopsy to confirm the diagnosis, and to check how bad the liver damage is.

What are the treatments for fatty liver disease?

Doctors recommend weight loss for nonalcoholic fatty liver. Weight loss can reduce fat in the liver, inflammation, and fibrosis. If your doctor thinks that a certain medicine is the cause of your NAFLD, you should stop taking that medicine. But check with your doctor before stopping the medicine. You may need to get off the medicine gradually, and you might need to switch to another medicine instead.

There are no medicines that have been approved to treat NAFLD. Studies are investigating whether a certain diabetes medicine or Vitamin E can help, but more studies are needed.

The most important part of treating alcohol-related fatty liver disease is to stop drinking alcohol. If you need help doing that, you may want to see a therapist or participate in an alcohol recovery program. There are also medicines that can help, either by reducing your cravings or making you feel sick if you drink alcohol.

Both alcoholic fatty liver disease and one type of nonalcoholic fatty liver disease (nonalcoholic steatohepatitis) can lead to cirrhosis. Doctors can treat the health problems caused by cirrhosis with medicines, operations, and other medical procedures. If the cirrhosis leads to liver failure, you may need a liver transplant.

What are some lifestyle changes that can help with fatty liver disease?

If you have any of the types of fatty liver disease, there are some lifestyle changes that can help:

  • Eat a healthy diet, limiting salt and sugar, plus eating lots of fruits, vegetables, and whole grains
  • Get vaccinations for hepatitis A and B, the flu and pneumococcal disease. If you get hepatitis A or B along with fatty liver, it is more likely to lead to liver failure. People with chronic liver disease are more likely to get infections, so the other two vaccinations are also important.
  • Get regular exercise, which can help you lose weight and reduce fat in the liver
  • Talk with your doctor before using dietary supplements, such as vitamins, or any complementary or alternative medicines or medical practices. Some herbal remedies can damage your liver.

Check out the latest treatments for LIVER FUNCTION TEST ABNORMAL

LIVER FUNCTION TEST ABNORMAL treatment research studies

Genteal clinical trials, surveys and public health registries


Find Drug Side Effect reports



Genteal Side Effects

Eye Irritation (30)
Eye Pain (25)
Vision Blurred (18)
Eye Pruritus (17)
Ocular Hyperaemia (16)
Pruritus (16)
Cataract (11)
Cataract Operation (9)
Dry Eye (8)
Eyelid Disorder (8)
Corneal Abrasion (7)
Eye Swelling (6)
Foreign Body Sensation In Eyes (6)
Lacrimation Increased (6)
Weight Decreased (4)
Fall (4)
Eye Infection (4)
Hypersensitivity (4)
Instillation Site Pain (3)
Corneal Disorder (3)
Keratitis (3)
Visual Acuity Reduced (3)
Superficial Injury Of Eye (3)
Ulcerative Keratitis (3)
Cerebrovascular Accident (2)
Cellulitis (2)
Anorexia (2)
Anaphylactic Shock (2)
Condition Aggravated (2)
Blepharospasm (2)
Death (2)
Pneumonia (2)
Dyspnoea (2)
Abnormal Sensation In Eye (2)
Diplopia (2)
Depression (2)
Conjunctival Ulcer (2)
Eye Inflammation (2)
Headache (2)
Intraocular Pressure Increased (2)
Hallucination, Visual (2)
Furuncle (2)
Eye Operation (2)
Large Intestinal Obstruction Reduction (2)
Lung Disorder (2)
Eye Discharge (2)
Plastic Surgery (2)
Memory Impairment (2)
Malaise (2)
Eye Burns (2)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

After using Genteal, my face broke out in a rash

At 58, suffering from severe, chronic dry eye (age- & Lasik-related), my ophthalmologist inserted punctal 'plugs' and advised buying GenTeal eye drops, as they 'have no preservatives.' I've now spent a week with increasing eye irritation/burn

First time user of Genteal Lubricant eye gel. After using this gel about 3 times, the inner part of my eye lid next to the nose (both eyes) became very red and raw. Had to go to an optician and he said if it

My father (83 yrs old) underwent Glaucoma and cataract surgery (left eye only ; right eye had acute Glaucoma and was difficult to be improved) on 31st July 2009. As advised, He recently got checked up by another local doctor because of blurred vision

This product is bad in my opinion! I will never recommend this product to anyone!

after EEG test doctor suggested valporate de sodium. the hair falling and leg problems are increasing day by day. We reported the doctor but he did not take action

When I reported to my doctor that i was frequently having to urinate he had a blood test carried out with the result that my prostrate was OK he prescribed Permixon 160 mg twice per day and Tamsulosina STADA 0,4 mg once per day. I am now urinating

Why do doctors keep the availabilty of the test for DPD deficiency a secret??? My sister is a doctor, infectious disease, at St Francis in Charleston, SC. Our father was treated by an oncologist well known to my sister, a 'colleague' you might s

why is my doctor checking my liver functions before he represcribes my synthoid that I have been on for over 20 years now?

after taking my medicine .i felt abnormal taste in mouth and my bilurubin level was increased.

<b>After taking this drug I suffered abdominal pain with diarrhea after eating even small amounts, pain developed with the urge to get to a toilet at once. I had a full blood and liver test and a stool test and all was normal.&nbs

<b>Describe Your Gastrografin Experience Here:</b>Itching, rash and diarrhea. Started as soon as test was finished. I ended up in the ER. I have an allergy to contrast dye. After reading about Gastrografin I see it contains Iodine.

<b>Describe Your Protium (pantoprazole, Injection) Experience Here:</b> my father has given pentaprajole at the dose of 40mg per day after 5 days the eyes have become yellow so we had taken test of bilirubin it shows 2.9 mg%

I took centrum for almost one month.and I notice that my menstruation suddenly became abnormal in cycle..in short AMENNORHEA....until now iam almost 1 month and 3 days delayed and took pregnancy test but the result was

The St. Loree's Medi Shaver has made my life a lot easier to function at home since I left the hospital August 2008. I ask my wife how much it costs to replace it. I drop it one time and it is broken. Especial

LIVER FUNCTION TEST ABNORMAL Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
Conditions: Keratoconjunctivitis Due to Adenovirus;   Viral Shedding
Interventions: Drug: Zirgan;   Drug: Genteal gel
Outcome Measures: Time to Viral Eradication;   Development of sub-epithelial infiltrates;   Degree of Bulbar conjunctival Injection;   Second eye involvment
2 Recruiting A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Condition: Viral Conjunctivitis
Interventions: Drug: dexamethasone 0.1%/povidone-iodine 0.4%;   Drug: Artificial Tears
Outcome Measures: Conjunctival injection;   Conjunctival chemosis
3 Unknown  Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma
Conditions: Ocular Surface Disease;   Glaucoma
Interventions: Drug: hydroxypropylmethylcellulose;   Drug: sodium hyaluronate
Outcome Measures: Ocular surface index score;   Eye lid inflammation, corneal staining score, tear break up time and tear volume
4 Not yet recruiting Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: bimatoprost 0.01%;   Drug: travoprost 0.004%;   Drug: timolol 0.5%;   Drug: hypromellose 0.3%
Outcome Measure: Intraocular Pressure (IOP) in the Study Eye
5 Recruiting An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: bimatoprost 0.01%;   Drug: travatan 0.004%;   Drug: timolol 0.5%;   Drug: hypromellose 0.3%
Outcome Measure: Intraocular Pressure (IOP) in the Study Eye
6 Recruiting Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Condition: Niemann-Pick Disease, Type C1
Intervention: Drug: 2-hydroxypropyl-beta-cyclodextrin
Outcome Measures: 24-hydroxycholesterol Area under the curve;   Hearing loss.
7 Recruiting The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: Lotemax;   Drug: Artificial Tears
Outcome Measures: In Vivo Confocal Microscopy (IVCM): Superficial corneal epithelial cells: Density, size, and hypereflectivity;   In Vivo Confocal Microscopy: Corneal subbasal immune dendritiform cells: Density, size, and cell field;   In Vivo Confocal Microscopy: Corneal subbasal nerves: Number and length of the main nerves and the branches;   Ocular Signs: Corneal epitheliopathy;   Ocular Signs: Conjunctival epitheliopathy;   Ocular Signs: Tear Break Up Time (TBUT);   Ocular Signs: Schirmer's Test with Anesthesia;   Ocular Signs: Intraocular pressure (IOP) by measure of applanation tonometry;   Ocular Symptoms: Ocular Surface Disease Index (OSDI) questionnaire;   Ocular Symptoms: • Symptom Assessment iN Dry Eye (SANDE) questionnaire
8 Unknown  Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage
Condition: Hordeolum
Interventions: Drug: neomycin sulfate, polymyxin B sulfate and gramicidin;   Drug: Artificial tear
Outcome Measures: Pain scale;   Mass size and duration of cure
9 Recruiting Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
Condition: Dry Eye
Interventions: Drug: FML 0.1% eyedrops;   Drug: Liquifilm artificial tears eyedrops
Outcome Measures: Fluorescein corneal staining;   Symptom Assessment in Dry Eye (SANDE) I and II questionnaire;   Tear inflammatory molecule levels;   Best corrected visual acuity;   Biomicroscopy findings at slit lamp examination;   Adverse events during the trial;   Other Efficacy Measures;   Intraocular pressure (IOP) and fundus examination
10 Recruiting Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Syndrome
Intervention: Drug: dexamethasone, artificial tears
Outcome Measure: Changes in ocular surface measured by routine opthalmic dyes
11 Recruiting Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects
Condition: Healthy
Interventions: Drug: Timoptic® 0.5%;   Drug: Timophtal sine® 0.5%;   Device: Genteal HA®;   Device: Hylo-Comod®;   Device: Thealoz®
Outcome Measures: Tear film thickness;   Break up time (BUT)
12 Recruiting Fluorometholone as Ancillary Therapy for TT Surgery
Conditions: Trichiasis;   Trachoma;   Bilamellar Tarsal Rotation
Interventions: Drug: Fluorometholone 0.1% ophthalmic solution;   Other: Artificial tears (Placebo)
Outcome Measures: Safety assessments;   Recurrence of trichiasis in the study eye
13 Not yet recruiting Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
Condition: Dry Eye Syndrome
Interventions: Device: Genteal HA® Eye Drops (NOVARTIS, Switzerland);   Other: Physiological Sodium Chloride solution (0,9%)
Outcome Measures: Tear film thickness;   Schirmer I Test;   Tear Break Up Time;   Ocular Surface Disease Index
14 Recruiting A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Condition: Dry Eye Disease
Interventions: Drug: Loteprednol etabonate;   Drug: Artificial Tears;   Drug: Restasis
Outcome Measures: Fluorescein corneal staining scores;   Lissamine green conjunctival staining
15 Not yet recruiting Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
Condition: Graves' Ophthalmopathy
Interventions: Drug: Bimatoprost;   Drug: Eye drop solution
Outcome Measures: The primary endpoint of this study will be comparison of the change in ophthalmometry readings over the two 3 month treatment periods.;   Change in quality of life scores on the TED quality of life questionnaire (GO-QOL);   Intraocular pressures;   Side effects;   Health economic outcomes
16 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port Wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.
Outcome Measure: Appearance of Port-wine Mark at treatment site
17 Recruiting Steroids After Laser Trabeculoplasty for Glaucoma
Condition: Glaucoma
Interventions: Drug: Prednisolone 1%;   Drug: Diclofenac 0.1%;   Drug: Artificial Tears
Outcome Measures: Intraocular pressure (IOP) lowering;   Intraocular inflammation
18 Unknown  Aqueous Humor Dynamics and Brimonidine
Condition: Intraocular Pressure
Interventions: Drug: Brimonidine;   Drug: Artificial tears
Outcome Measure: Aqueous Humor Dynamics
19 Recruiting Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery
Condition: Strabismus
Interventions: Drug: subtenons anesthetic - preservative-free bupivacaine 0.75%;   Drug: topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel;   Drug: topical control - 0.5 cc of Hypromellose 0.3% gel;   Drug: subtenons control - 0.5 cc of Normal Saline
Outcome Measures: Average pain score over the first 30 post-operative minutes using the CHEOPS scale;   Peak pain score in the first 30 minutes;   Total narcotic and anti-emetic use during post-operative recovery;   Negative postoperative behavior score on the PHBQ (post hospitalization behavioral questionnaire);   Change in pain score
20 Unknown  Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection
Condition: Large Polyps in the Gastrointestinal Tract
Interventions: Drug: Autologous blood injection;   Drug: Normal saline;   Drug: HPMC
Outcome Measures: Duration of the submucosal cushion Ease of injection Ability to complete lesion removal Post-procedure complications;   Ability to perform lesion removal Ability to visualize during the procedure